BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 16512388)

  • 1. [Beta-adrenoblockers in treatment of dilated cardiomyopathy].
    Novikov IuI; Konstantinova EV; Stulova MA
    Klin Med (Mosk); 2006; 84(1):11-6. PubMed ID: 16512388
    [No Abstract]   [Full Text] [Related]  

  • 2. [The treatment of dilated cardiomyopathy].
    Amosova EN
    Ter Arkh; 1994; 66(3):88-91. PubMed ID: 7911259
    [No Abstract]   [Full Text] [Related]  

  • 3. [Beta-receptor blockers in dilated cardiomyopathy].
    Osterziel KJ
    Dtsch Med Wochenschr; 1994 Nov; 119(46):1604-5. PubMed ID: 7956807
    [No Abstract]   [Full Text] [Related]  

  • 4. [Several aspects of the diagnosis of cardiomyopathies and patient management policy].
    Gasilin VS; Piskareva IN; Rozova NK; Potapkina IN; Bubnov IuP; Zvereva LV
    Ross Med Zh; 1992; (2):32-5. PubMed ID: 1353695
    [No Abstract]   [Full Text] [Related]  

  • 5. Congestive cardiomyopathy: treatment advances. Endomyocardial biopsy, new inotropes, beta-blockade.
    Slack JD; Nasser WK
    Indiana Med; 1986 Feb; 79(2):168-71. PubMed ID: 2869082
    [No Abstract]   [Full Text] [Related]  

  • 6. Reversible high rate atrial fibrillation dilated cardiomyopathy.
    Lazzari JO; Gonzalez J
    Heart; 1997 May; 77(5):486. PubMed ID: 9196425
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of circulatory diseases: recent progress. 4. Cardiomyopathies].
    Kawamura K
    Nihon Naika Gakkai Zasshi; 1986 Jul; 75(7):873-80. PubMed ID: 2878052
    [No Abstract]   [Full Text] [Related]  

  • 8. Beta-blockers in asymptomatic dilated cardiomyopathy: to b-block or not to b-block?
    Filippatos G; Kremastinos DT
    Eur Heart J; 2007 May; 28(9):1170-1. PubMed ID: 17412729
    [No Abstract]   [Full Text] [Related]  

  • 9. [Dilated cardiomyopathy].
    Gurevich MA; Iankovskaia MO
    Sov Med; 1985; (10):30-3. PubMed ID: 2867605
    [No Abstract]   [Full Text] [Related]  

  • 10. Dilated cardiomyopathy : clinical profile and treatment.
    Khalil A; Chawla K; Chakravarti A
    Indian Pediatr; 2000 Nov; 37(11):1242-6. PubMed ID: 11086307
    [No Abstract]   [Full Text] [Related]  

  • 11. Idiopathic dilated cardiomyopathy.
    Cooke CE
    N Engl J Med; 1995 May; 332(20):1384; author reply 1385-6. PubMed ID: 7715656
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacological treatment of supraventricular hyperkinetic arrhythmia in sinus node disease: an alternative to electric treatment].
    Pagnoni F; Arlotti M; Lotto A
    G Ital Cardiol; 1983; 13(5):408-11. PubMed ID: 6618064
    [No Abstract]   [Full Text] [Related]  

  • 13. Reversible cardiomyopathy.
    Dhadke SV; Dhadke VN
    J Assoc Physicians India; 2006 Sep; 54():740-1. PubMed ID: 17212027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of norepinephrine transporter and adrenergic receptor alpha1D are associated with the response to beta-blockers in dilated cardiomyopathy.
    Nonen S; Okamoto H; Fujio Y; Takemoto Y; Yoshiyama M; Hamaguchi T; Matsui Y; Yoshikawa J; Kitabatake A; Azuma J
    Pharmacogenomics J; 2008 Feb; 8(1):78-84. PubMed ID: 17404580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of medical therapy for heart failure on segmental myocardial function in patients with ischemic cardiomyopathy.
    Blondheim DS; Kazatsker M; Friedman Z; Lysyansky P; Meisel SR; Asif A; Smirin N; Shotan A
    Am J Cardiol; 2007 Jun; 99(12):1741-4. PubMed ID: 17560886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug information: agents for the treatment of arrhythmia. Therapeutic main group: anti-arrhythmia agents. 12. Adrenergic beta receptor blockaders].
    Lumholtz IB
    Sygeplejersken; 1980 Nov; 80(46):11. PubMed ID: 6108622
    [No Abstract]   [Full Text] [Related]  

  • 17. Beta 1-adrenergic receptor-directed autoimmunity as a cause of dilated cardiomyopathy in rats.
    Jahns R; Boivin V; Lohse MJ
    Int J Cardiol; 2006 Sep; 112(1):7-14. PubMed ID: 16872696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the pathophysiology is the key to novel therapies for canine dilated cardiomyopathy.
    Elliott J; Marr CM
    Vet J; 2001 Nov; 162(3):168-9. PubMed ID: 11681866
    [No Abstract]   [Full Text] [Related]  

  • 19. [Timing of heart transplantation for dilated cardiomyopathy].
    Toshima H
    Nihon Naika Gakkai Zasshi; 1993 Feb; 82(2):240-5. PubMed ID: 8098352
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of LB-46, a new anti-arrhythmic agent, during anesthesia.
    Yoshikawa K; Tosaki Y; Yoshiya I
    Med J Osaka Univ; 1972 Dec; 23(2):189-97. PubMed ID: 4148141
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.